IntelliLung Intelligent Lung Support for Mechanically Ventilated Patients in the Intensive Care Unit
- Coordinator
- Technische Universitaet Dresden, Germany
- Runs
- 1 September 2022 to 31 August 2027
- Status
- Running
- EU funding
- €6.0m
- Total cost
- €6.0m
- Partners
- 20 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057434
What the project is doing
In the project's own words, from its summary on CORDIS.
Invasive mechanical ventilation (MV) is one of the most important and life-saving therapies in the intensive care unit (ICU). In most severe cases, when MV alone is insufficient, extracorporeal lung support (ELS) is initiated. However, MV is recognised as potentially harmful, because inappropriate MV settings in ICU patients are associated with organ damage, contributing to disease burden. Studies revealed that MV is often not properly provided despite clear evidence and guidelines.
Furthermore, treatment decisions by the healthcare providers, especially regarding MV and ELS, often remain incomprehensible to the patients and their relatives, since flow of information from caregivers to patients is challenged by a number of factors, including limited time and resources, communication problems as well as patients? capacity to comprehend and memorise information. The project proposed herein aims at clinically validating and extending our IntelliLung Artificial Intelligence Decision Support System (AI-DSS) designed to optimise MV and ELS settings to improve the care of ICU patients, alongside caregiver-patient communication.
Thereby, best practice evidence-based MV and ELS within safer therapy corridors for longer periods, faster weaning from MV, and improved survival could be achieved - even in non-experienced hands. Additionally, this project will improve the information flow from caregivers to patients and relatives in the ICU setting. Therefore, we will develop a digital solution that allows automatic generation of an extensive plain-language information package for patients and their relatives, communicating highly individualised information on diseases and knowledge-based disease-management strategies, thus facilitating high-quality current and subsequent care through health literacy empowerment and patient-centredness.
We will perform a retrospective and prospective multi-centre study to validate our IntelliLung AI-DSS and the patient information software.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Technische Universitaet Dresden | Dresden | Germany | Coordinator |
| European Society of Anaesthesiology and Intensive Care Aisbl | Bruxelles / Brussel | Belgium | Participant |
| Insel Gruppe AG | Bern | Switzerland | Associatedpartner |
| Institut Fur Angewandte Informatik (infai) eV | Leipzig | Germany | Participant |
| Was Hab' Ich? Gemeinnutzige GmbH | Dresden | Germany | Participant |
| Better Care SL | Sabadell | Spain | Participant |
| Corporacio Sanitaria Parc Tauli De Sabadell | Sabadell | Spain | Third party |
| Fundacio Institut D'investigació I Innovació Parc Tauli | Sabadell | Spain | Participant |
| Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa | Madrid | Spain | Third party |
| Fundacion Publica Andaluza Progreso Y Salud M.p. | Sevilla | Spain | Participant |
| Servicio Madrileno De Salud | Madrid | Spain | Participant |
| Irccs Azienda Ospedaliera Metropolitana | Genova | Italy | Third party |
| Universita Degli Studi Di Genova | Genova | Italy | Participant |
| Demcon Innovation & Technology B.v. | Enschede | Netherlands | Third party |
| Demcon Life Sciences & Healtheindhoven B.v. | Best | Netherlands | Third party |
| Demcon Macawi Respiratory Systems BV | Enschede | Netherlands | Participant |
| Demcon Life Sciences & Health Maastricht B.V. | Enschede | Netherlands | Third party |
| Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji | Warszawa | Poland | Participant |
| Institut Mihajlo Pupin | Beograd | Serbia | Participant |
| The Cleveland Clinic Foundation | Cleveland | United States | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI